Generics

Filter

Current filters:

None

Popular Filters

56 to 80 of 1233 results

Lupin no longer trying to market generics of Truvada and Viread

Lupin no longer trying to market generics of Truvada and Viread

08-06-2014

Indian drugmaker Lupin seems to have abandoned plans to bring to market generic versions of Gilead Sciences’…

Anti-viralsGenericsGilead SciencesLegalLupinPatentsTruvadaUSAViread

Fight the Fakes campaign gains momentum as 11 new partners join global movement

Fight the Fakes campaign gains momentum as 11 new partners join global movement

06-06-2014

Following the campaign’s six-month anniversary, Fight the Fakes has announced 11 new partners, bringing…

GenericsGlobalMarkets & Marketing

Ranbaxy’s Toansa plant assessment concluded: no risk to public health, EU view

Ranbaxy’s Toansa plant assessment concluded: no risk to public health, EU view

05-06-2014

European regulatory authorities have finalized their assessment of reported non-compliance with Good…

EuropeGenericsIndiaProductionRanbaxy LaboratoriesRegulation

Generic and biosimilar drugs should be key components of CSRs for health, says EGA

Generic and biosimilar drugs should be key components of CSRs for health, says EGA

05-06-2014

The increased number of health related proposed country specific recommendations (CSR) to European Union…

BiosimilarsGenericsHealthcareRegulation

European generics group welcomes WHA resolution on biotherapeutics products

04-06-2014

The European Generic Medicines Association (EGA) has welcomed the 67th World Health Assembly’s Resolution…

BiosimilarsGenericsGlobalRegulation

EGA calls for international regulatory cooperation

03-06-2014

European Generics Medicines Association (EGA) Director General Adrian van den Hoven last week joined…

GenericsGlobalPharmaceutical industryRegulationResearch

AMRI to buy Oso Biopharmaceuticals Manufacturing for $110 million

AMRI to buy Oso Biopharmaceuticals Manufacturing for $110 million

02-06-2014

USA-based Albany Molecular Research has signed a definitive agreement to acquire all of the outstanding…

Albany Molecular ResearchGenericsMergers & AcquisitionsOso BiopharmaceuticalsProduction

Actavis brings escitalopram to market after patent expiry

Actavis brings escitalopram to market after patent expiry

02-06-2014

Generics major Actavis (NYSE: ACT) has launched escitalopram tablets in the UK today, following the patent…

ActavisCNS DiseasesEscitalopramEscitalopram OxalateGenericsLexaproLundbeckPatentsUK

Actavis settles Nuvigil patent litigation with Cephalon

Actavis settles Nuvigil patent litigation with Cephalon

01-06-2014

Ireland-headquartered generics major Actavis says it has entered into an agreement with Cephalon to settle…

ActavisCephalonGenericsLegalNeurologicalNuvigilPatentsTeva Pharmaceutical IndustriesUSA

European and Japanese generics groups view opportunities on biosimilars

European and Japanese generics groups view opportunities on biosimilars

29-05-2014

The European Generic Medicines Association (EGA) participated in several meetings with Japanese government…

BiosimilarsEuropeGenericsJapanMarkets & MarketingRegulation

Hikma to buy Boehringer’s Bedford Labs unit for $300 million

Hikma to buy Boehringer’s Bedford Labs unit for $300 million

28-05-2014

Jordon-based drugmaker Hikma Pharmaceuticals has signed an asset purchase agreement with Ben Venue Laboratories,…

Bedford LaboratoriesBoehringer IngelheimGenericsHikma PharmaceuticalsMergers & AcquisitionsUSA

Actavis challenges AstraZeneca’s diabetes drug Onglyza patent in the USA

Actavis challenges AstraZeneca’s diabetes drug Onglyza patent in the USA

28-05-2014

Generics major Actavis yesterday confirmed that it has filed an Abbreviated New Drug Application with…

ActavisAstraZenecaDiabetesGenericsOnglyzaPatentsUSA

Recordati finalizes second tranche of Opalia Pharma acquisition

27-05-2014

Following previous announcements about its M&A activity, Italian drugmaker Recordati has now announced…

GenericsMergers & AcquisitionsOpalia PharmaRecordatiRest of the World

Congressional hearing in Brazil will discuss the efficacy of generic medicines

26-05-2014

The Brazilian Commission for Consumer Protection will soon hold a hearing to discuss the effectiveness…

BrazilGenericsPoliticsRegulation

Indian court ruling lifts temporary stay on Sun Pharma takeover of Ranbaxy

26-05-2014

Indian generics drugmaker Sun Pharmaceuticals’ proposed $3.2 billion acquisition of loss-making rival…

Daiichi SankyoGenericsLegalMergers & AcquisitionsRanbaxy LaboratoriesSun Pharmaceuticals

Prasco to market authorized generic of NeoProfen Injection

22-05-2014

Privately held US generic drugmaker Prasco Laboratories has entered into a distribution and supply agreement…

GenericsLicensingNeoProfenNeurologicalPrasco LaboratoriesRecordatiUSA

Russian PM visits country's first commercial manufacturing plant for MAb-based therapeutic proteins

20-05-2014

Russian Prime Minister Dmitri Medvedev on Monday visited the commercial manufacturing facility for monoclonal…

BiocadBiosimilarsGenericsOncologyProductionRussia

Abbott spends $2.9 billion on CFR Pharma to expand Latin American presence

16-05-2014

US drugmaker Abbott has signed an agreement to acquire Latin American pharmaceutical company CFR Pharmaceuticals,…

Abbott LaboratoriesCFR PharmaceuticalsGenericsMergers & AcquisitionsSouth America

Lilly loses out in UK Alimta vitamin dosage regimen patent law suit

16-05-2014

US pharma major Eli Lilly says that the English High Court has determined that the vitamin dosage regimen…

ActavisAlimtaEli LillyGenericsLegalOncologyPatentsUK

Generic drugs will be a key element of Mexico's health care modernization; report

16-05-2014

Although Mexico has made great efforts to improve its regulatory framework and create a more hospitable…

GenericsHealthcareMarkets & MarketingMexico

US Court rejects Teva’s Copaxone appeal

15-05-2014

A US district court has dismissed a case by Israeli drugmaker Teva Pharmaceutical Industries intended…

CopaxoneGenericsLegalMylanNeurologicalPatentsTeva Pharmaceutical IndustriesUSA

Novartis patent settlement on Gleevec with Sun Pharma subsidiary

15-05-2014

The US unit of Swiss drug major Novartis has settled its litigation with the US subsidiary of India’s…

GenericsGleevecNovartisOncologyPatentsSun Pharmaceutical IndustriesUSA

56 to 80 of 1233 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top